Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-09T21:36:10.697Z Has data issue: false hasContentIssue false
  • English
  • Français

The Development of Cuba’s Biotechnology: Mechanisms and Challenges

Published online by Cambridge University Press:  29 December 2023

Omar Everleny Perez Villanueva  and
Juan Carlos Albizu-Campos Espiñeira Open the ORCID record for Juan Carlos Albizu-Campos Espiñeira [Opens in a new window]
Omar Everleny Perez Villanueva
Affiliation:
CENTER FOR REFLECTION AND DIALOGUE, CUBA
Juan Carlos Albizu-Campos Espiñeira
Affiliation:
UNIVERSITY OF HAVANA, CUBA
Get access Rights & Permissions [Opens in a new window]

Abstract

Cuba faces a dilemma between continuing its current portfolio of biotechnology drugs and vaccines with lower profitability or renewing its product portfolio with the associated costs and risks.

Keywords

CubaBiotechnologyDrugsVaccinesRisks
Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 51 , Issue S1: Rethinking Pharmaceutical Policies in Latin America and the Caribbean , Fall 2023 , pp. 136 - 147
Copyright
© 2023 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

BioCubaFarma, Productos, 2023, available at <biocubafarma.cu/productos/productos.php>..>Google Scholar
Lage, A., “Science and Challenges for Cuban Public Health in the 21st Century,” MEDICC Review 21 (2019): 7–14.Google Scholar
Lage, A., “Connecting Science to Population Health: The ‘Closed Loop’ Approach,” MEDICC Review 9 (2007): 48.Google ScholarPubMed
BioCubaFarma, supra note 1; Sierra-González, V.G., “Cuban Meningococcal Vaccine VA-MENGOC-BC: 30 Years of Use and Future Potential,” MEDICC Review 21 (2019): 19–27.Google ScholarPubMed
Zhou, Q., et al., “Interferon-α2b Treatment for COVID-19,” Frontiers in Immunology 11 (2020): 1061.CrossRefGoogle ScholarPubMed
López-Saura, P.A., et al., “Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic Foot Ulcers,” Advancements in Pharmacoepidemiology Drug Safety 2 (2013): 128.Google Scholar
O. Pérez Villanueva, “Biotechnology Development in Cuba: Challenges in the Economic Strategy Beyond 2021 | Cuba Capacity Building Project,” available at <https://horizontecubano.law.columbia.edu/news/biotechnology-development-cuba-challenges-economic-strategy-beyond-2021> (last visited September 13, 2023).+(last+visited+September+13,+2023).>Google Scholar
Machado, C. Castellanos and Bendoyro, J., El capital relacional en el sector biotecnológico cubano (Marta Abreu de las Villas, 2008).Google Scholar
Delgado, B. García, Di Fabio, J.L., Casanovas, J. Vidal, Fitzgerald, J., Silva, A.P., “Salud pública y propiedad intelectual en Cuba: mapa conceptual,” Revista Panamericana de Salud Pública 38 (2015): 355–361.Google Scholar
Delgado, B. García, Di Fabio, J.L., and Casanovas, J. Vidal, “Mapa conceptual sobre salud pública y propiedad intelectual en Cuba: actualización 2020,” Revista Panamericana de Salud Pública 44 (2020); B. García, E. Díaz, and E.M. Fajardo, Experiencia local en la producción local de medicamentos, transferencia de tecnología y mejoramiento en el acceso a la salud, Segunda Edición (2020).Google Scholar
WIPO, WIPO IP Statistics Data Center, 2023.Google Scholar
J. Aboites, T. Beltrán, and A. Guzmán, “Quién apropia el conocimiento producido por los inventores?” Habana IV Seminario Internacion sobre Estududios Cuantitativos y Cualitivos Inf. INFO (2008); Pérez, M. Díaz, Reyes, R. Giráldez, and Carrillo-Calvet, H.A., “Metric Behavior of Patents Granted in Cuba: Its Contribution to the National Technological Innovation,” Investig. Bibl. 31 (2017): 271–289; Ministry of Sciences & Technology, Cuba Statistics Yearbook (2023).Google Scholar
See García Delgado, et al., supra notes 9 and 10.Google Scholar
C. Martinez Diaz, Régimen jurídico de las creaciones intelectuales surgidas en el marco de relaciones laborales y de colaboración (2023).Google Scholar
See Díaz Pérez and Ministry of Sciences & Technology, supra note 12.Google Scholar
See García, et al., supra note 10.Google Scholar
See García Delgado, et al., supra notes 9 and 10.Google Scholar
Valerino, D.R.P., “Ciencia, salud y diplomacia: simbiosis necesaria en el escenario actual de las Relaciones Internacionales,” Revista Política Internacional (2020): 111–121.Google Scholar
See Zhou, supra note 5.Google Scholar
Díaz, E.M., Rodríguez, R.P., Martínez, L.H., Dávila, A.L., and Serra, L.C., “La industria biofarmacéutica cubana en el combate contra la pandemia de COVID-19,” Anales de la Academia de Ciencias de Cuba 10 (2020): 906.Google Scholar
Toledo-Romaní, M.E., et al., “Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-Plus: A Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial,” The Lancet Regional Health 18 (2023).Google ScholarPubMed
Más-Bermejo, P.I., et al., “Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; A Cohort Study,” The Lancet Regional Health - Americas 16 (2022): 100366; F. Hernández-Bernal, et al., “A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial Evaluation of the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine in Adults (ABDALA-3 Study),” The Lancet Regional Health 21 (2023).CrossRefGoogle ScholarPubMed
Reardon, S., “Cuba’s Bet on Home-Grown COVID Vaccines Is Paying Off,” Nature 15–16 (2021): 15–16.CrossRefGoogle Scholar
ONEI, Anuario estadístico de Cuba: Sección sector externo (2022).Google Scholar
B. Fernandez Perez, “Impacto económico y social de la industria biotecnológica Cubana,” available at <www.gestiopolis.com/impacto-economico-y-social-de-la-industria-biotecnologica-cubana> (last visited September 13, 2023).+(last+visited+September+13,+2023).>Google Scholar